Criterion Capital Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$1.99M Hold
2,201
1.25% 21
2024
Q3
$1.99M Hold
2,201
1.25% 21
2024
Q2
$1.99M Sell
2,201
-28
-1% -$22.4K 1.25% 21
2024
Q1
$1.73M Sell
2,229
-68
-3% -$48.4K 1.16% 27
2023
Q4
$1.34M Buy
+2,297
New +$1.34M 0.97% 28

Other funds holding LLY

Criterion Capital Advisors's LLY Position: Q4 2024 in Review

Criterion Capital Advisors held its Eli Lilly (LLY) position steady in Q4 2024 at 2,201 shares worth $1.99M. The position accounts for 1.25% of the portfolio, ranked #21.

Criterion Capital Advisors first reported a position in LLY in Q4 2023 and has held it in 5 quarters since. 3,906 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

  • Criterion Capital Advisors held 2,201 shares of Eli Lilly worth $1.99M as of Q4 2024.
  • Criterion Capital Advisors left its Eli Lilly share count unchanged in Q4 2024.
  • Eli Lilly made up 1.25% of Criterion Capital Advisors's portfolio in Q4 2024, its #21 holding.
  • Criterion Capital Advisors first reported a position in Eli Lilly in Q4 2023 and has held it in 5 quarters since.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on Criterion Capital Advisors's 13F filing for Q4 2024, filed 10 Feb 2025.